Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SSTR4 | P31391 | 10/20 | 0.81 |
| ▸ | SSTR2 | P30874 | 16/20 | 0.80 |
| ▸ | SSTR5 | P35346 | 11/20 | 0.80 |
| ▸ | SSTR3 | P32745 | 4/20 | 0.78 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23901126 | 0.91 | SSTR2 (0.88) | SSTR4SSTR2SSTR5SSTR3 | |
| SCHEMBL23482744 | 0.91 | SSTR2 (0.88) | SSTR4SSTR2SSTR5SSTR3 | |
| SCHEMBL24685237 | 0.91 | SSTR4 (0.80) | SSTR4SSTR2SSTR5SSTR3 | |
| SCHEMBL22388803 | 0.91 | SSTR2 (0.87) | SSTR4SSTR2SSTR5SSTR3 | |
| SCHEMBL22389054 | 0.91 | SSTR2 (0.87) | SSTR4SSTR2SSTR5SSTR3 | |
| SCHEMBL25504914 | 0.91 | SSTR2 (0.87) | SSTR4SSTR2SSTR5SSTR3 | |
| SCHEMBL10044662 | 0.91 | SSTR4 (0.81) | SSTR4SSTR2SSTR5SSTR3 | |
| SCHEMBL30338443 | 0.91 | SSTR2 (0.86) | SSTR4SSTR2SSTR5SSTR3 | |
| SCHEMBL21312714 | 0.90 | SSTR4 (0.78) | SSTR4SSTR2SSTR5SSTR3 | |
| SCHEMBL180440 | 0.90 | SSTR4 (0.83) | SSTR4SSTR2SSTR5SSTR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180078656-A1 | CRYPTOPHYCIN-BASED ANTIBODY-DRUG CONJUGATES WITH NOVEL SELF-IMMOLATIVE LINKERS | EXIRIS S.R.L. (IT) | 2018-03-22 | — | — | US | disclosed |
| WO-2016146638-A1 | CRYPTOPHYCIN-BASED ANTIBODY-DRUG CONJUGATES WITH NOVEL SELF-IMMOLATIVE LINKERS | EXIRIS S.R.L. (IT) | 2016-09-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180078656-A1 | CRYPTOPHYCIN-BASED ANTIBODY-DRUG CONJUGATES WITH NOVEL SELF-IMMOLATIVE LINKERS | DNPEP, CDC16, PREP | SSTR4 634/4885SSTR2 1096/4885SSTR5 731/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.